Roland Wolkowicz

Title: Roland Wolkowicz: Innovator in Anti-Tumor Immunity

Introduction

Roland Wolkowicz is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions aimed at inducing anti-tumor immunity. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.

Latest Patents

Wolkowicz's latest patents focus on immunogenic compositions for the induction of anti-tumor immunity. The first patent relates to methods of inducing an anti-tumor immunity and/or immune responses to p53 in mammals. The methods involve administering an effective amount of at least one immunogen, which is preferably a peptide ranging from 7 to 30 amino acid residues in length. This peptide contains sequences from the CDR2 or CDR3 of the heavy chain, or the CDR3 of the light chain of an anti-p53 monoclonal antibody.

Career Highlights

Wolkowicz is associated with Yeda Research and Development Co. Ltd., where he continues to innovate in the field of immunology. His work has garnered attention for its potential impact on cancer therapies and immune response enhancement.

Collaborations

He has collaborated with notable colleagues such as Irun R Cohen and Varda Rotter, contributing to a rich environment of research and development in immunogenic therapies.

Conclusion

Roland Wolkowicz's contributions to the field of anti-tumor immunity through his innovative patents highlight his role as a key figure in advancing cancer treatment methodologies. His ongoing work promises to make significant strides in immunology and therapeutic applications.